DE69613168D1 - Verwendung eines CGRP Antagonisten zur Behandlung von Flechten und Pruritus und so erhaltene Zubereitung - Google Patents
Verwendung eines CGRP Antagonisten zur Behandlung von Flechten und Pruritus und so erhaltene ZubereitungInfo
- Publication number
- DE69613168D1 DE69613168D1 DE69613168T DE69613168T DE69613168D1 DE 69613168 D1 DE69613168 D1 DE 69613168D1 DE 69613168 T DE69613168 T DE 69613168T DE 69613168 T DE69613168 T DE 69613168T DE 69613168 D1 DE69613168 D1 DE 69613168D1
- Authority
- DE
- Germany
- Prior art keywords
- lichen
- pruritus
- preparation
- treatment
- cgrp antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940127597 CGRP antagonist Drugs 0.000 title 1
- 208000003251 Pruritus Diseases 0.000 title 1
- 239000003735 calcitonin gene related peptide receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9503627A FR2732220B1 (fr) | 1995-03-28 | 1995-03-28 | Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue |
FR9503627 | 1995-03-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69613168D1 true DE69613168D1 (de) | 2001-07-12 |
DE69613168T2 DE69613168T2 (de) | 2001-09-27 |
DE69613168T3 DE69613168T3 (de) | 2009-03-05 |
Family
ID=9477497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69613168T Expired - Lifetime DE69613168T3 (de) | 1995-03-28 | 1996-03-04 | Verwendung eines CGRP-Antagonisten zur Behandlung von Lichen und Pruritus und erhaltene Zusammensetzung |
Country Status (14)
Country | Link |
---|---|
US (1) | US5935586A (de) |
EP (1) | EP0734728B2 (de) |
JP (1) | JP3043610B2 (de) |
AR (1) | AR001435A1 (de) |
AT (1) | ATE201828T1 (de) |
BR (1) | BR9601467A (de) |
CA (1) | CA2172778C (de) |
DE (1) | DE69613168T3 (de) |
ES (1) | ES2159697T5 (de) |
FR (1) | FR2732220B1 (de) |
HU (1) | HUP9600764A3 (de) |
MX (1) | MX9601151A (de) |
PL (1) | PL313511A1 (de) |
RU (1) | RU2152785C1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
JP2001233764A (ja) * | 2000-02-22 | 2001-08-28 | Hisamitsu Pharmaceut Co Inc | N−置換−o−トルイジン誘導体からなる鎮痒剤 |
MXPA05001649A (es) | 2002-08-12 | 2005-05-27 | Birkir Sveinsson | Uso de compuestos antagonistas del cgrp para tratamiento de la psoriasis. |
US11517612B2 (en) | 2016-11-18 | 2022-12-06 | Nepsone Ehf | Methods of treating inflammatory skin disorders |
US8168592B2 (en) * | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
PL2380592T3 (pl) | 2005-11-14 | 2018-07-31 | Teva Pharmaceuticals International Gmbh | Przeciwciało antagonistyczne skierowane przeciwko peptydowi powiązanemu z genem kalcytoniny |
WO2009109911A1 (en) | 2008-03-04 | 2009-09-11 | Pfizer Limited | Methods of treating chronic pain |
RU2535074C2 (ru) | 2009-08-28 | 2014-12-10 | Лэйбрис Байолоджикс, Инк. | Способы лечения висцеральной боли путем введения антител-антагонистов, направленных против пептида, связанного с геном кальцитонина |
US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
LT3119431T (lt) | 2014-03-21 | 2024-03-12 | Teva Pharmaceuticals International Gmbh | Antagonistiniai antikūnai, nukreipti prieš peptidą, susijusį su kalcitonino genu, ir jų panaudojimo būdai |
KR101593793B1 (ko) * | 2014-04-29 | 2016-02-12 | 한전케이피에스 주식회사 | 리프트 행거 및 그 리프트 행거를 사용하여 리프트를 설치하는 방법 |
CN109952314A (zh) | 2016-09-23 | 2019-06-28 | 泰瓦制药国际有限公司 | 治疗难治性偏头痛 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9201425D0 (sv) * | 1992-05-06 | 1992-05-06 | Kabi Pharmacia Ab | Method and means for preventing constriction of the pupil in the eye |
US5445823A (en) * | 1994-10-20 | 1995-08-29 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith |
-
1995
- 1995-03-28 FR FR9503627A patent/FR2732220B1/fr not_active Expired - Lifetime
-
1996
- 1996-03-04 DE DE69613168T patent/DE69613168T3/de not_active Expired - Lifetime
- 1996-03-04 EP EP96400456A patent/EP0734728B2/de not_active Expired - Lifetime
- 1996-03-04 ES ES96400456T patent/ES2159697T5/es not_active Expired - Lifetime
- 1996-03-04 AT AT96400456T patent/ATE201828T1/de not_active IP Right Cessation
- 1996-03-26 BR BR9601467A patent/BR9601467A/pt active Search and Examination
- 1996-03-27 RU RU96105824/14A patent/RU2152785C1/ru active
- 1996-03-27 AR ARP960101927A patent/AR001435A1/es unknown
- 1996-03-27 HU HU9600764A patent/HUP9600764A3/hu unknown
- 1996-03-27 MX MX9601151A patent/MX9601151A/es unknown
- 1996-03-27 PL PL96313511A patent/PL313511A1/xx unknown
- 1996-03-27 JP JP8072772A patent/JP3043610B2/ja not_active Expired - Lifetime
- 1996-03-27 CA CA002172778A patent/CA2172778C/fr not_active Expired - Lifetime
- 1996-03-28 US US08/620,805 patent/US5935586A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH08268904A (ja) | 1996-10-15 |
HU9600764D0 (en) | 1996-05-28 |
DE69613168T3 (de) | 2009-03-05 |
BR9601467A (pt) | 1998-03-31 |
EP0734728A1 (de) | 1996-10-02 |
ATE201828T1 (de) | 2001-06-15 |
HUP9600764A3 (en) | 1998-03-02 |
AR001435A1 (es) | 1997-10-22 |
ES2159697T5 (es) | 2008-07-01 |
JP3043610B2 (ja) | 2000-05-22 |
CA2172778C (fr) | 2008-02-12 |
MX9601151A (es) | 1997-02-28 |
US5935586A (en) | 1999-08-10 |
EP0734728B1 (de) | 2001-06-06 |
HUP9600764A2 (en) | 1997-06-30 |
CA2172778A1 (fr) | 1996-09-29 |
FR2732220B1 (fr) | 1997-04-25 |
EP0734728B2 (de) | 2008-02-13 |
RU2152785C1 (ru) | 2000-07-20 |
FR2732220A1 (fr) | 1996-10-04 |
DE69613168T2 (de) | 2001-09-27 |
PL313511A1 (en) | 1996-09-30 |
ES2159697T3 (es) | 2001-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69600399D1 (de) | Verwendung von einem CGRP Antagonist für dir Behandlung von Hauterythemen neurogenischen Ursprung und erhaltene Zubearbeitung | |
DE69622074D1 (de) | Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien | |
DE69830728D1 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
DE69631157D1 (de) | Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes | |
ATE331522T1 (de) | Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum | |
DE69720463T2 (de) | Sulfonamid-derivate und ihre verwendung zur behandlung von zns-erkrankungen | |
NO962179L (no) | Fremgangsmåte for fremstilling av metallocen og anvendelse derav | |
DE69505657D1 (de) | Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren | |
DE69115921D1 (de) | Verfahren zur behandlung und verwendung von abfallstoffen | |
DE3780972D1 (de) | Verwendung von spezifischen n-methyl-d-aspartat-rezeptor-antagonisten zur praevention und behandlung von neurodegeneration. | |
ATA11989A (de) | Mittel zur vorbeugung gegen und behandlung von parodontopathien | |
DE69613168D1 (de) | Verwendung eines CGRP Antagonisten zur Behandlung von Flechten und Pruritus und so erhaltene Zubereitung | |
DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
DE69310303D1 (de) | Gerät zur topografischen Bestimmung anatomischer Oberflächen, insbesondere der Kornea | |
DE69306915D1 (de) | Kombination zur Detektion von Weichgewebeanomalien | |
ATE204177T1 (de) | Verwendung von substanz p antagonist im pharmazeutischer zusammensetzung | |
DE69426848D1 (de) | Gerät zur Behandlung von lichtempfindlichen Materialien | |
FI973254A0 (fi) | Menetelmä aminoetyylietanoliamiinin ja/tai hydroksietyylipiperatsiinin valmistamiseksi | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
DE69635977D1 (de) | Verfahren zur Bestimmung der therapeutischen Wirkung von Metalloproteinase-Verbindungen, neue Inhibitor-Verbindungen und deren therapeutische Verwendung | |
DE69716896D1 (de) | Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
KR960702749A (ko) | 심장혈관 질환의 치료를 위한 천연물 및 이와 관련된 합성 화합물의 사용(Use of Natural Products and Related Synthetic Compounds for the Treatment of Cardiovascular Disease) | |
DE69614739D1 (de) | Pflaster zur Behandlung von Pflanzen | |
DE69133390D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |